Three-dimensional microstructural properties of regenerated mineralizing tissue after PTH (1-34) treatment in a rabbit tibial lengthening model.
暂无分享,去创建一个
I. Hvid | M. Lind | H. Eckardt | J. Thomsen | K. Bundgaard | R. Aleksyniene
[1] I. Hvid,et al. Parathyroid hormone PTH(1–34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits , 2009, Acta orthopaedica.
[2] S. Kakar,et al. Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. , 2008, The Journal of bone and joint surgery. American volume.
[3] R. Recker,et al. Increases in BMD Correlate With Improvements in Bone Microarchitecture With Teriparatide Treatment in Postmenopausal Women With Osteoporosis , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] D. Burr,et al. Interrelationships Between Bone Microarchitecture and Strength in Ovariectomized Monkeys Treated With Teriparatide , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] N. Lane,et al. Parathyroid hormone update. , 2006, Rheumatic diseases clinics of North America.
[6] T. Thomas. Intermittent parathyroid hormone therapy to increase bone formation. , 2006, Joint, bone, spine : revue du rhumatisme.
[7] T. Einhorn,et al. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. , 2005, Bone.
[8] S Prohaska,et al. Stereological measures of trabecular bone structure: comparison of 3D micro computed tomography with 2D histological sections in human proximal tibial bone biopsies , 2005, Journal of microscopy.
[9] B. Mitlak,et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). , 2005, The Journal of bone and joint surgery. American volume.
[10] S. Komatsubara,et al. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. , 2005, Bone.
[11] P. Aspenberg,et al. Intermittent parathyroid hormone (1–34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[12] J. F. Whitfield,et al. Treatment with Parathyroid Hormone hPTH(1-34), hPTH(1-31), and Monocyclic hPTH(1-31) Enhances Fracture Strength and Callus Amount After Withdrawal Fracture Strength and Callus Mechanical Quality Continue to Increase , 2004, Calcified Tissue International.
[13] H. Genant,et al. Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] R. Skripitz,et al. Histomorphometry of Distraction Osteogenesis During Experimental Tibial Lengthening , 2003, Journal of orthopaedic trauma.
[15] W. Landis,et al. Organization of apatite crystals in human woven bone. , 2003, Bone.
[16] J. Reginster,et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.
[17] C. Fledelius,et al. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone , 2001, Acta orthopaedica Scandinavica.
[18] I. Hvid,et al. Quantification of age-related changes in the structure model type and trabecular thickness of human tibial cancellous bone. , 2000, Bone.
[19] P. Aspenberg,et al. Strong effect of PTH (1-34) on regenerating bone: A time sequence study in rats , 2000, Acta orthopaedica Scandinavica.
[20] S A Goldstein,et al. Temporal and Spatial Characterization of Regenerate Bone in the Lengthened Rabbit Tibia , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] L. Mosekilde,et al. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis). , 1999, Bone.
[22] P. Rüegsegger,et al. Direct Three‐Dimensional Morphometric Analysis of Human Cancellous Bone: Microstructural Data from Spine, Femur, Iliac Crest, and Calcaneus , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] H. Oxlund,et al. Intermittent Parathyroid Hormone (1–34) Treatment Increases Callus Formation and Mechanical Strength of Healing Rat Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] Toru Hirano,et al. Anabolic Effects of Human Biosynthetic Parathyroid Hormone Fragment (1–34), LY333334, on Remodeling and Mechanical Properties of Cortical Bone in Rabbits , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] T. Wronski,et al. Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats. , 1999, Bone.
[26] P. Rüegsegger,et al. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. , 1998, Bone.
[27] H. Takahashi,et al. Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. , 1997, Bone.
[28] J Aronson,et al. Limb-lengthening, skeletal reconstruction, and bone transport with the Ilizarov method. , 1997, The Journal of bone and joint surgery. American volume.
[29] R. Boyce,et al. Effects of intermittent hPTH(1–34) alone and in combination with 1,25(OH)2d3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] D. Thompson,et al. FDA Guidelines and animal models for osteoporosis. , 1995, Bone.
[31] L. Mosekilde. Assessing bone quality--animal models in preclinical osteoporosis research. , 1995, Bone.
[32] I. Hvid,et al. Distraction effects on muscle. Leg lengthening studied in rabbits. , 1994, Acta orthopaedica Scandinavica.
[33] H. Gundersen,et al. Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. , 1993, Bone.
[34] S. Goldstein,et al. Evaluation of a microcomputed tomography system to study trabecular bone structure , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[35] G A Ilizarov,et al. The tension-stress effect on the genesis and growth of tissues: Part II. The influence of the rate and frequency of distraction. , 1989, Clinical orthopaedics and related research.
[36] S. Goldstein,et al. The direct examination of three‐dimensional bone architecture in vitro by computed tomography , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] R. Recker,et al. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84. , 2009, Bone.
[38] 真鍋 健史. Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys , 2008 .
[39] P. Rüegsegger,et al. A microtomographic system for the nondestructive evaluation of bone architecture , 2006, Calcified Tissue International.
[40] I. Hvid,et al. Effects of parathyroid hormone on newly regenerated bone during distraction osteogenesis in a rabbit tibial lengthening model. A pilot study. , 2006, Medicina.
[41] R. Lindsay,et al. The Anabolic Effects of Parathyroid Hormone , 2002, Osteoporosis International.
[42] J. Reeve,et al. Treatment with PTH Peptides , 2001 .
[43] Gavriil A. Ilizarov,et al. The Tension-Stress Effect on the Genesis and Growth of Tissues , 1992 .
[44] W. Jee,et al. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats. , 1990, Bone.
[45] C. Delloye,et al. Bone regenerate formation in cortical bone during distraction lengthening. An experimental study. , 1990, Clinical orthopaedics and related research.
[46] G A Ilizarov,et al. Clinical application of the tension-stress effect for limb lengthening. , 1990, Clinical orthopaedics and related research.
[47] G A Ilizarov,et al. The tension-stress effect on the genesis and growth of tissues. Part I. The influence of stability of fixation and soft-tissue preservation. , 1989, Clinical orthopaedics and related research.